X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (14) 14
index medicus (12) 12
oncology (12) 12
male (11) 11
aged (7) 7
middle aged (7) 7
prostate cancer (7) 7
metastasis (5) 5
research (5) 5
adenocarcinoma (4) 4
aged, 80 and over (4) 4
animals (4) 4
cancer (4) 4
chemotherapy (4) 4
neoplasm staging (4) 4
prostatic neoplasms, castration-resistant - drug therapy (4) 4
urology & nephrology (4) 4
abiraterone acetate (3) 3
antineoplastic agents, hormonal - therapeutic use (3) 3
carcinoma, non-small-cell lung - drug therapy (3) 3
care and treatment (3) 3
castration (3) 3
clinical medicine (3) 3
current smokers (3) 3
docetaxel (3) 3
double-blind (3) 3
increased survival (3) 3
lung neoplasms - drug therapy (3) 3
non-small cell lung cancer (3) 3
phase-iii trial (3) 3
prednisone - administration & dosage (3) 3
therapy (3) 3
treatment outcome (3) 3
urology (3) 3
abiraterone (2) 2
adenocarcinoma - mortality (2) 2
adult (2) 2
analysis (2) 2
antigens (2) 2
antineoplastic agents - administration & dosage (2) 2
antineoplastic agents - therapeutic use (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
asco special (2) 2
cancer and oncology (2) 2
cancer och onkologi (2) 2
carcinoma, non-small-cell lung - pathology (2) 2
clinical trials, phase iii as topic (2) 2
clinical-trials (2) 2
cyber resilience (2) 2
cyber security (2) 2
drug administration schedule (2) 2
endocrinology & metabolism (2) 2
enzalutamide (2) 2
epidemiology (2) 2
evaluation (2) 2
gdln1 (2) 2
growth (2) 2
immunotherapy (2) 2
infrastruktur (2) 2
klinisk medicin (2) 2
lung cancer (2) 2
lung neoplasms - pathology (2) 2
medical and health sciences (2) 2
medical prognosis (2) 2
medicin och hälsovetenskap (2) 2
metastases (2) 2
mitoxantrone (2) 2
multivariate analysis (2) 2
neoplasm metastasis (2) 2
never smokers (2) 2
oncology, experimental (2) 2
pain (2) 2
phosphatases (2) 2
placebo (2) 2
prednisone - adverse effects (2) 2
prednisone - therapeutic use (2) 2
prospective studies (2) 2
prostate-specific antigen - blood (2) 2
prostatic neoplasms - drug therapy (2) 2
prostatic neoplasms, castration-resistant - pathology (2) 2
quality of life (2) 2
quality-of-life (2) 2
radioisotopes - administration & dosage (2) 2
radium (2) 2
radium - administration & dosage (2) 2
randomized controlled trials as topic (2) 2
recommendation engine (2) 2
safety (2) 2
service-qualität (2) 2
surgery (2) 2
survival (2) 2
taxoids - administration & dosage (2) 2
taxoids - therapeutic use (2) 2
thor5 (2) 2
urologi och njurmedicin (2) 2
urology and nephrology (2) 2
1,25-dihydroxyvitamin-d3 (1) 1
abiraterone acetate - administration & dosage (1) 1
abiraterone acetate - adverse effects (1) 1
abridged index medicus (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
The Prostate, ISSN 0270-4137, 04/2017, Volume 77, Issue 5, pp. 479 - 488
Journal Article
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 11/2018, Volume 24, Issue 21, pp. 5225 - 5232
Purpose: Seviteronel (INO-464) is a selective cytochrome P450c17a (CYP17) 17,20-lyase (lyase) and androgen receptor (AR) inhibitor with antitumor activity in... 
THERAPY | ANTIANDROGEN | ONCOLOGY | BIOSYNTHESIS | GROWTH | ABIRATERONE ACETATE | INCREASED SURVIVAL | CLINICAL ACTIVITY | CHEMOTHERAPY | DEFICIENCY | ENZALUTAMIDE
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2014, Volume 32, Issue 15_suppl, pp. e16093 - e16093
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2019, Volume 37, Issue 7_suppl, pp. TPS681 - TPS681
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2018, Volume 36, Issue 6_suppl, pp. TPS538 - TPS538
TPS538 Background: Despite initial high response rates to current SoC first-line chemotherapy, most patients with locally advanced or metastatic urothelial... 
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2019, Volume 37, Issue 7_suppl, pp. 169 - 169
Journal Article
Clinical cancer research : an official journal of the American Association for Cancer Research, ISSN 1078-0432, 07/2018
Seviteronel (INO-464) is a selective cytochrome P450c17a (CYP17) 17,20-lyase (lyase) and androgen receptor (AR) inhibitor with anti-tumor activity in vitro and... 
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2015, Volume 33, Issue 7_suppl, pp. 187 - 187
187 Background: VT-464 is an oral, non-steroidal inhibitor of CYP17-L and an antagonist of androgen receptor (AR) variants F876L and T877A which are associated... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.